COMBINATION CHEMOTHERAPY FOR METASTATIC OR RECURRENT ADENOCARCINOMA OF THE CERVIX

被引：15

作者：

KAVANAGH, JJ ^{[1
]}

GERSHENSON, D ^{[1
]}

COPELAND, L ^{[1
]}

ROBERTS, WS ^{[1
]}

机构：

[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT GYNECOL,HOUSTON,TX 77030

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1987年 / 5卷 / 10期

关键词：

D O I：

10.1200/JCO.1987.5.10.1621

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1621 / 1623

页数：3

共 18 条

[1]

BEREK JS, 1985, OBSTET GYNECOL, V65, P46

[2]

CAVANAGH D, 1985, GYNECOLOGIC CANCER C, P86

[3]

CLEMENT PB, 1982, SEMIN ONCOL, V9, P251

[4] ICRF-159 (RAZOXANE) IN PATIENTS WITH ADVANCED NONSQUAMOUS CELL-CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY [J].

HOMESLEY, HD ;

BLESSING, JA ;

BERMAN, M .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1986, 9 (04) :325-326

[5]

IRELAND D, 1985, OBSTET GYNECOL, V65, P82

[6] ADENOCARCINOMA OF UTERINE CERVIX [J].

KAGAN, AR ;

NUSSBAUM, H ;

CHAN, PYM ;

ZIEL, HK .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1973, 117 (04) :464-468

[7]

KORHONEN MO, 1984, CANCER, V53, P1760, DOI 10.1002/1097-0142(19840415)53:8<1760::AID-CNCR2820530824>3.0.CO

[8]

2-4

[9] REDUCTION OF DOXORUBICIN CARDIOTOXICITY BY PROLONGED CONTINUOUS INTRAVENOUS-INFUSION [J].

LEGHA, SS ;

BENJAMIN, RS ;

MACKAY, B ;

EWER, M ;

WALLACE, S ;

VALDIVIESO, M ;

RASMUSSEN, SL ;

BLUMENSCHEIN, GR ;

FREIREICH, EJ .

ANNALS OF INTERNAL MEDICINE, 1982, 96 (02) :133-139

[10]

MOBERG PJ, 1986, CANCER, V57, P407, DOI 10.1002/1097-0142(19860115)57:2<407::AID-CNCR2820570239>3.0.CO

← 1 2 →